申请人:Farmitalia Carlo Erba S.r.l.
公开号:US05364854A1
公开(公告)日:1994-11-15
Derivatives of 2,3,3a,4-tetrahydro-2-azabicyclo alkyl-1H-imidazo[5,1,-c][1,4]benzoxazin-1-one are provided of general formula (I) ##STR1## in which inter alia R.sub.3 represents ##STR2## wherein n is an integer of 1 or 2 and R.sub.8 is hydrogen, C.sub.1 -C.sub.6 alkyl unsubstituted or substituted by phenyl, C.sub.2 -C.sub.4 alkenyl, C.sub.2 -C.sub.4 alkynyl, formyl or C.sub.2 -C.sub.6 alkanoyl; and the pharmaceutically acceptable salts thereof, which are useful in the treatment of CNS disorders, gut motility disorders, emesis and migraine, as cognition activators, anti-drug addiction agents and analgesic.
提供了2,3,3a,4-四氢-2-氮杂双环烷烷基-1H-咪唑[5,1,-c][1,4]苯并噁嗪-1-酮的衍生物,其一般公式为(I)。其中,R.sub.3代表其中之一##STR2##其中n是1或2的整数,R.sub.8是氢、未取代或取代为苯基、C.sub.2 -C.sub.4烯基、C.sub.2 -C.sub.4炔基、甲酰基或C.sub.2 -C.sub.6脂肪酰的C.sub.1 -C.sub.6烷基;以及其药学上可接受的盐。这些衍生物在治疗中枢神经系统疾病、胃肠动力障碍、恶心和偏头痛方面有用,可作为认知激活剂、抗药物成瘾剂和镇痛剂。